Efficacy and safety of levosulpiride versus metoclopramide in patients with emesis induced by high doses of salmon calcitonin

G. F. Schiraldi, S. Lo Cicero, G. M. Parodi, A. Masoudi, G. Cimino, R. Boffi, F. A. Triscari, M. Ciccarelli, S. Scoccia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The antiemetic activity of levosulpiride 25 mg IV was compared with that of metoclopramide 10 mg IV in 30 patients with bone metastasis secondary to pulmonary carcinoma who were treated with intravenous salmon calcitonin. In this randomized, double-blind, crossover study, levosulpiride was significantly more effective than metoclopramide in reducing the intensity of nausea and the number of vomiting episodes. No differences were seen when the drugs were administered in the first or second cycle of therapy, indicating that there was no carryover effect of one drug on the other. Levosulpiride was significantly better tolerated than metoclopramide. Not only did levosulpiride induce fewer side effects (11 versus 42 for metoclopramide), but it also reduced the number of undesired events caused by the elevated doses of salmon calcitonin (20 versus 48 for metoclopramide).

Original languageEnglish
Pages (from-to)42-47
Number of pages6
JournalCurrent Therapeutic Research
Volume53
Issue number1
DOIs
Publication statusPublished - 1993

Fingerprint

salmon calcitonin
Metoclopramide
Vomiting
Safety
Antiemetics
Double-Blind Method
Pharmaceutical Preparations
Cross-Over Studies
Nausea
levosulpiride
Neoplasm Metastasis
Carcinoma
Bone and Bones
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Efficacy and safety of levosulpiride versus metoclopramide in patients with emesis induced by high doses of salmon calcitonin. / Schiraldi, G. F.; Lo Cicero, S.; Parodi, G. M.; Masoudi, A.; Cimino, G.; Boffi, R.; Triscari, F. A.; Ciccarelli, M.; Scoccia, S.

In: Current Therapeutic Research, Vol. 53, No. 1, 1993, p. 42-47.

Research output: Contribution to journalArticle

Schiraldi, G. F. ; Lo Cicero, S. ; Parodi, G. M. ; Masoudi, A. ; Cimino, G. ; Boffi, R. ; Triscari, F. A. ; Ciccarelli, M. ; Scoccia, S. / Efficacy and safety of levosulpiride versus metoclopramide in patients with emesis induced by high doses of salmon calcitonin. In: Current Therapeutic Research. 1993 ; Vol. 53, No. 1. pp. 42-47.
@article{3b24262ae5534f8787a304970a9bded2,
title = "Efficacy and safety of levosulpiride versus metoclopramide in patients with emesis induced by high doses of salmon calcitonin",
abstract = "The antiemetic activity of levosulpiride 25 mg IV was compared with that of metoclopramide 10 mg IV in 30 patients with bone metastasis secondary to pulmonary carcinoma who were treated with intravenous salmon calcitonin. In this randomized, double-blind, crossover study, levosulpiride was significantly more effective than metoclopramide in reducing the intensity of nausea and the number of vomiting episodes. No differences were seen when the drugs were administered in the first or second cycle of therapy, indicating that there was no carryover effect of one drug on the other. Levosulpiride was significantly better tolerated than metoclopramide. Not only did levosulpiride induce fewer side effects (11 versus 42 for metoclopramide), but it also reduced the number of undesired events caused by the elevated doses of salmon calcitonin (20 versus 48 for metoclopramide).",
author = "Schiraldi, {G. F.} and {Lo Cicero}, S. and Parodi, {G. M.} and A. Masoudi and G. Cimino and R. Boffi and Triscari, {F. A.} and M. Ciccarelli and S. Scoccia",
year = "1993",
doi = "10.1016/S0011-393X(05)80154-7",
language = "English",
volume = "53",
pages = "42--47",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "1",

}

TY - JOUR

T1 - Efficacy and safety of levosulpiride versus metoclopramide in patients with emesis induced by high doses of salmon calcitonin

AU - Schiraldi, G. F.

AU - Lo Cicero, S.

AU - Parodi, G. M.

AU - Masoudi, A.

AU - Cimino, G.

AU - Boffi, R.

AU - Triscari, F. A.

AU - Ciccarelli, M.

AU - Scoccia, S.

PY - 1993

Y1 - 1993

N2 - The antiemetic activity of levosulpiride 25 mg IV was compared with that of metoclopramide 10 mg IV in 30 patients with bone metastasis secondary to pulmonary carcinoma who were treated with intravenous salmon calcitonin. In this randomized, double-blind, crossover study, levosulpiride was significantly more effective than metoclopramide in reducing the intensity of nausea and the number of vomiting episodes. No differences were seen when the drugs were administered in the first or second cycle of therapy, indicating that there was no carryover effect of one drug on the other. Levosulpiride was significantly better tolerated than metoclopramide. Not only did levosulpiride induce fewer side effects (11 versus 42 for metoclopramide), but it also reduced the number of undesired events caused by the elevated doses of salmon calcitonin (20 versus 48 for metoclopramide).

AB - The antiemetic activity of levosulpiride 25 mg IV was compared with that of metoclopramide 10 mg IV in 30 patients with bone metastasis secondary to pulmonary carcinoma who were treated with intravenous salmon calcitonin. In this randomized, double-blind, crossover study, levosulpiride was significantly more effective than metoclopramide in reducing the intensity of nausea and the number of vomiting episodes. No differences were seen when the drugs were administered in the first or second cycle of therapy, indicating that there was no carryover effect of one drug on the other. Levosulpiride was significantly better tolerated than metoclopramide. Not only did levosulpiride induce fewer side effects (11 versus 42 for metoclopramide), but it also reduced the number of undesired events caused by the elevated doses of salmon calcitonin (20 versus 48 for metoclopramide).

UR - http://www.scopus.com/inward/record.url?scp=0027481409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027481409&partnerID=8YFLogxK

U2 - 10.1016/S0011-393X(05)80154-7

DO - 10.1016/S0011-393X(05)80154-7

M3 - Article

VL - 53

SP - 42

EP - 47

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 1

ER -